Quoin Pharmaceuticals Ltd. (QNRX) Form S-3 — Oct 27, 2026
Quoin Pharmaceuticals filed a new $150,000,000 shelf registration statement on Form S-3, allowing it to offer ADSs, warrants, subscription rights, debt securities, and units from time to time as market conditions permit. No securities are being sold in this filing, and terms of any future offering would come via prospectus supplements. Under the baby-shelf rules, Quoin is capped at selling securities worth more than one-third of its roughly $36.4 million public float in any 12-month period while its float remains below $75 million.
Key figures
- Gross Proceeds
- 150000000
- Shares Outstanding
- 168145635
- Ads ratio
- 1 ADS = 35 ordinary shares
- Ads outstanding
- 4804161
- Public float usd
- 36422384
- Non affiliate ads
- 4628003
- Closing price date
- 2026-10-23
- Last closing price
- 4.02
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.